{"id":5099,"date":"2022-05-05T00:55:47","date_gmt":"2022-05-05T00:55:47","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=5099"},"modified":"2023-08-29T17:53:58","modified_gmt":"2023-08-29T17:53:58","slug":"argenica-closer-clinical-studies-stroke-drug-arg-007-following-positive-preclinical-safety-results","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=5099","title":{"rendered":"\u5728\u83b7\u5f97\u79ef\u6781\u7684\u4e34\u5e8a\u524d\u5b89\u5168\u6027\u7ed3\u679c\u540e\uff0cArgenica \u79bb\u4e2d\u98ce\u836f\u7269 ARG-007 \u7684\u4e34\u5e8a\u7814\u7a76\u66f4\u8fd1\u4e86\u4e00\u6b65"},"content":{"rendered":"

Argenica Therapeutics (ASX: AGN) \u4e2d\u98ce\u836f\u7269 ARG-007 \u7684\u4e34\u5e8a\u524d\u5b89\u5168\u6027\u7814\u7a76\u5df2\u6210\u529f\u5b8c\u6210\uff0c\u8fd9\u4e3a 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4f26\u7406\u63d0\u4ea4\u94fa\u5e73\u4e86\u9053\u8def\u3002<\/p>\n

Argenica \u7684\u836f\u7269 ARG-007 \u5df2\u88ab\u5f00\u53d1\u7528\u4e8e\u51cf\u5c11\u4e2d\u98ce\u540e\u7684\u8111\u7ec4\u7ec7\u6b7b\u4ea1\uff0c\u5b89\u5168\u836f\u7406\u5b66\u4e34\u5e8a\u524d\u7814\u7a76\u5df2\u5bfc\u81f4\u89c2\u5bdf\u5230\u201c\u6ca1\u6709\u5f02\u5e38\u75c7\u72b6\u201d\u3002<\/p>\n

\u8fd9\u4e9b\u7814\u7a76\u662f\u5728\u826f\u597d\u5b9e\u9a8c\u5ba4\u89c4\u8303\u76d1\u7ba1\u6846\u67b6\u4e0b\u8fdb\u884c\u7684\uff0c\u5e76\u8bc4\u4f30\u4e86\u5bf9\u5927\u9f20\u548c\u975e\u4eba\u7c7b\u7075\u957f\u7c7b\u52a8\u7269\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u548c\u547c\u5438\u7cfb\u7edf\u7684\u5f71\u54cd\u3002<\/p>\n

\u8fd9\u4e9b\u7814\u7a76\u65e8\u5728\u63ed\u793a\u836f\u7269\u5bf9\u4e3b\u8981\u751f\u7406\u7cfb\u7edf\u7684\u4efb\u4f55\u4e0d\u5229\u5f71\u54cd\u3002<\/p>\n

\u52a8\u7269\u5728\u6709\u6548\u6cbb\u7597\u8303\u56f4\u5185\u63a5\u53d7 ARG-007\uff0c\u76f4\u81f3\u6700\u5927\u8010\u53d7\u5242\u91cf\u3002<\/p>\n

Argenica \u9996\u5e2d\u6267\u884c\u5b98 Liz Dallimore \u535a\u58eb\u8868\u793a\uff0c\u8be5\u516c\u53f8\u5bf9\u5b89\u5168\u6027\u7814\u7a76\u201c\u975e\u5e38\u9f13\u821e\u201d\uff0c\u8be5\u7814\u7a76\u8868\u660e\u5373\u4f7f\u5728\u9ad8\u5242\u91cf\u7684ARG-007 \u4e0b\u4e5f\u6ca1\u6709\u89c2\u5bdf\u5230\u5f02\u5e38\u5f71\u54cd\u3002<\/p>\n

\u201c\u8fd9\u7ed9\u4e86\u6211\u4eec\u5f88\u5927\u7684\u4fe1\u5fc3\uff0c\u56e0\u4e3a\u6211\u4eec\u51c6\u5907\u63d0\u4ea4\u4f26\u7406\u6587\u4ef6\u4ee5\u83b7\u5f97\u6211\u4eec\u5373\u5c06\u8fdb\u884c\u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u6279\u51c6\uff0c\u201d\u5979\u8865\u5145\u8bf4\u3002<\/p>\n

\u63a8\u8fdb\u4e3b\u8981\u5019\u9009\u4eba ARG-007<\/h2>\n

Argenica \u5728 3 \u6708\u5b63\u5ea6\u7684\u91cd\u70b9\u662f\u5b8c\u6210\u8ba1\u5212\u4e2d\u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u6240\u9700\u7684\u51c6\u5907\u5de5\u4f5c\uff0c\u5305\u62ec\u7597\u6548\u548c\u4eca\u5929\u5ba3\u5e03\u7684\u5b89\u5168\u6027\u7814\u7a76\u7ed3\u679c\u3002<\/p>\n

\u4e34\u5e8a\u8bd5\u9a8c\u5269\u4e0b\u7684\u552f\u4e00\u6570\u636e\u6765\u81ea\u6bd2\u7406\u5b66\u548c\u836f\u4ee3\u52a8\u529b\u5b66\u7814\u7a76\u7684\u6700\u7ec8\u75c5\u7406\u5b66\u8bc4\u4f30\u3002<\/p>\n

\u9884\u8ba1\u5c06\u201c\u5f88\u5feb\u201d\u6536\u5230\u3002<\/p>\n

\u4f26\u7406\u63d0\u4ea4\u8ba1\u5212\u5728\u672c\u5b63\u5ea6\u63d0\u4ea4\uff0c\u7b2c\u4e00\u9636\u6bb5\u8bd5\u9a8c\u5c06\u5728\u5065\u5eb7\u4eba\u7c7b\u5fd7\u613f\u8005\u4e2d\u8fdb\u884c\uff0c\u4ee5\u8bc4\u4f30\u5355\u6b21\u9012\u589e\u5242\u91cf ARG-007 \u7684\u5b89\u5168\u6027\u3001\u8010\u53d7\u6027\u548c\u836f\u4ee3\u52a8\u529b\u5b66\u3002<\/p>\n

\u9884\u8ba1\u5c06\u6709 32 \u4eba\u53c2\u52a0\u8bd5\u9a8c\uff0c\u7ed3\u679c\u5c06\u4e3a Argenica \u63d0\u4f9b\u6709\u5173\u5176\u4e3b\u8981\u5019\u9009\u4eba\u7684\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\u7684\u5173\u952e\u6570\u636e\u3002<\/p>\n

\u8be5\u7ed3\u679c\u8fd8\u5c06\u7528\u4e8e\u7b2c 2 \u671f\u8bd5\u9a8c\uff0c\u5176\u4e2d ARG-007 \u5c06\u7528\u4e8e\u4e2d\u98ce\u60a3\u8005\uff0c\u4ee5\u786e\u5b9a\u662f\u5426\u5728\u5c11\u6570\u4eba\u7c7b\u60a3\u8005\u4e2d\u89c2\u5bdf\u5230\u7597\u6548\u3002<\/p>\n

\u9664\u4e86\u5bf9\u4e2d\u98ce\u60a3\u8005\u7684\u7814\u7a76\u5916\uff0cArgenica \u8fd8\u5728\u7814\u7a76 ARG-007 \u5728\u5176\u4ed6\u7c7b\u578b\u8111\u635f\u4f24\u4e2d\u7684\u7ed3\u679c\uff0c\u5e76\u5728 3 \u6708\u5b63\u5ea6\u516c\u5e03\u4e86\u8be5\u836f\u7269\u5bf9\u8111\u7f3a\u8840\u5f71\u54cd\u7684\u79ef\u6781\u4e34\u5e8a\u524d\u7ed3\u679c\u3002<\/p>\n

\u8111\u7f3a\u8840\u662f\u6307\u5927\u8111\u7684\u8840\u6db2\u4e2d\u65ad\uff0c\u53ef\u80fd\u53d1\u751f\u5728\u5fc3\u810f\u9aa4\u505c\u548c\u67d0\u4e9b\u5fc3\u810f\u624b\u672f\u671f\u95f4\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

Argenica Therapeutics (ASX: AGN) \u4e2d\u98ce\u836f\u7269 ARG-007 \u7684\u4e34\u5e8a\u524d\u5b89\u5168\u6027\u7814\u7a76\u5df2\u6210\u529f\u5b8c\u6210\uff0c\u8fd9\u4e3a 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4f26\u7406\u63d0\u4ea4\u94fa\u5e73\u4e86\u9053\u8def\u3002 Argenica \u7684\u836f\u7269 ARG-007 \u5df2\u88ab\u5f00\u53d1\u7528\u4e8e\u51cf\u5c11\u4e2d\u98ce\u540e\u7684\u8111\u7ec4\u7ec7\u6b7b\u4ea1\uff0c\u5b89\u5168\u836f\u7406\u5b66\u4e34\u5e8a\u524d\u7814\u7a76\u5df2\u5bfc\u81f4\u89c2\u5bdf\u5230\u201c\u6ca1\u6709\u5f02\u5e38\u75c7\u72b6\u201d\u3002 \u8fd9\u4e9b\u7814\u7a76\u662f\u5728\u826f\u597d\u5b9e\u9a8c\u5ba4\u89c4\u8303\u76d1\u7ba1\u6846\u67b6\u4e0b\u8fdb\u884c\u7684\uff0c\u5e76\u8bc4\u4f30\u4e86\u5bf9\u5927\u9f20\u548c\u975e\u4eba\u7c7b\u7075\u957f\u7c7b\u52a8\u7269\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u548c\u547c\u5438\u7cfb\u7edf\u7684\u5f71\u54cd\u3002 \u8fd9\u4e9b\u7814\u7a76\u65e8\u5728\u63ed\u793a\u836f\u7269\u5bf9\u4e3b\u8981\u751f\u7406\u7cfb\u7edf\u7684\u4efb\u4f55\u4e0d\u5229\u5f71\u54cd\u3002 \u52a8\u7269\u5728\u6709\u6548\u6cbb\u7597\u8303\u56f4\u5185\u63a5\u53d7 ARG-007\uff0c\u76f4\u81f3\u6700\u5927\u8010\u53d7\u5242\u91cf\u3002 Argenica \u9996\u5e2d\u6267\u884c\u5b98 Liz Dallimore \u535a\u58eb\u8868\u793a\uff0c\u8be5\u516c\u53f8\u5bf9\u5b89\u5168\u6027\u7814\u7a76\u201c\u975e\u5e38\u9f13\u821e\u201d\uff0c\u8be5\u7814\u7a76\u8868\u660e\u5373\u4f7f\u5728\u9ad8\u5242\u91cf\u7684ARG-007 \u4e0b\u4e5f\u6ca1\u6709\u89c2\u5bdf\u5230\u5f02\u5e38\u5f71\u54cd\u3002 \u201c\u8fd9\u7ed9\u4e86\u6211\u4eec\u5f88\u5927\u7684\u4fe1\u5fc3\uff0c\u56e0\u4e3a\u6211\u4eec\u51c6\u5907\u63d0\u4ea4\u4f26\u7406\u6587\u4ef6\u4ee5\u83b7\u5f97\u6211\u4eec\u5373\u5c06\u8fdb\u884c\u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u6279\u51c6\uff0c\u201d\u5979\u8865\u5145\u8bf4\u3002 \u63a8\u8fdb\u4e3b\u8981\u5019\u9009\u4eba ARG-007 Argenica \u5728 3 \u6708\u5b63\u5ea6\u7684\u91cd\u70b9\u662f\u5b8c\u6210\u8ba1\u5212\u4e2d\u7684 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u6240\u9700\u7684\u51c6\u5907\u5de5\u4f5c\uff0c\u5305\u62ec\u7597\u6548\u548c\u4eca\u5929\u5ba3\u5e03\u7684\u5b89\u5168\u6027\u7814\u7a76\u7ed3\u679c\u3002 \u4e34\u5e8a\u8bd5\u9a8c\u5269\u4e0b\u7684\u552f\u4e00\u6570\u636e\u6765\u81ea\u6bd2\u7406\u5b66\u548c\u836f\u4ee3\u52a8\u529b\u5b66\u7814\u7a76\u7684\u6700\u7ec8\u75c5\u7406\u5b66\u8bc4\u4f30\u3002 \u9884\u8ba1\u5c06\u201c\u5f88\u5feb\u201d\u6536\u5230\u3002 \u4f26\u7406\u63d0\u4ea4\u8ba1\u5212\u5728\u672c\u5b63\u5ea6\u63d0\u4ea4\uff0c\u7b2c\u4e00\u9636\u6bb5\u8bd5\u9a8c\u5c06\u5728\u5065\u5eb7\u4eba\u7c7b\u5fd7\u613f\u8005\u4e2d\u8fdb\u884c\uff0c\u4ee5\u8bc4\u4f30\u5355\u6b21\u9012\u589e\u5242\u91cf ARG-007 \u7684\u5b89\u5168\u6027\u3001\u8010\u53d7\u6027\u548c\u836f\u4ee3\u52a8\u529b\u5b66\u3002 \u9884\u8ba1\u5c06\u6709 32 \u4eba\u53c2\u52a0\u8bd5\u9a8c\uff0c\u7ed3\u679c\u5c06\u4e3a Argenica \u63d0\u4f9b\u6709\u5173\u5176\u4e3b\u8981\u5019\u9009\u4eba\u7684\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\u7684\u5173\u952e\u6570\u636e\u3002 \u8be5\u7ed3\u679c\u8fd8\u5c06\u7528\u4e8e\u7b2c 2 \u671f\u8bd5\u9a8c\uff0c\u5176\u4e2d ARG-007 \u5c06\u7528\u4e8e\u4e2d\u98ce\u60a3\u8005\uff0c\u4ee5\u786e\u5b9a\u662f\u5426\u5728\u5c11\u6570\u4eba\u7c7b\u60a3\u8005\u4e2d\u89c2\u5bdf\u5230\u7597\u6548\u3002 \u9664\u4e86\u5bf9\u4e2d\u98ce\u60a3\u8005\u7684\u7814\u7a76\u5916\uff0cArgenica \u8fd8\u5728\u7814\u7a76 ARG-007 \u5728\u5176\u4ed6\u7c7b\u578b\u8111\u635f\u4f24\u4e2d\u7684\u7ed3\u679c\uff0c\u5e76\u5728 3 \u6708\u5b63\u5ea6\u516c\u5e03\u4e86\u8be5\u836f\u7269\u5bf9\u8111\u7f3a\u8840\u5f71\u54cd\u7684\u79ef\u6781\u4e34\u5e8a\u524d\u7ed3\u679c\u3002… Continue reading \u5728\u83b7\u5f97\u79ef\u6781\u7684\u4e34\u5e8a\u524d\u5b89\u5168\u6027\u7ed3\u679c\u540e\uff0cArgenica \u79bb\u4e2d\u98ce\u836f\u7269 ARG-007 \u7684\u4e34\u5e8a\u7814\u7a76\u66f4\u8fd1\u4e86\u4e00\u6b65<\/span><\/a><\/p>\n","protected":false},"author":3,"featured_media":13105,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[888],"yoast_head":"\n\u5728\u83b7\u5f97\u79ef\u6781\u7684\u4e34\u5e8a\u524d\u5b89\u5168\u6027\u7ed3\u679c\u540e\uff0cArgenica \u79bb\u4e2d\u98ce\u836f\u7269 ARG-007 \u7684\u4e34\u5e8a\u7814\u7a76\u66f4\u8fd1\u4e86\u4e00\u6b65<\/title>\n<meta name=\"description\" content=\"Argenica Therapeutics (ASX: AGN) \u4e2d\u98ce\u836f\u7269 ARG-007 \u7684\u4e34\u5e8a\u524d\u5b89\u5168\u6027\u7814\u7a76\u5df2\u6210\u529f\u5b8c\u6210\uff0c\u8fd9\u4e3a 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4f26\u7406\u63d0\u4ea4\u94fa\u5e73\u4e86\u9053\u8def\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u5728\u83b7\u5f97\u79ef\u6781\u7684\u4e34\u5e8a\u524d\u5b89\u5168\u6027\u7ed3\u679c\u540e\uff0cArgenica \u79bb\u4e2d\u98ce\u836f\u7269 ARG-007 \u7684\u4e34\u5e8a\u7814\u7a76\u66f4\u8fd1\u4e86\u4e00\u6b65\" \/>\n<meta property=\"og:description\" content=\"Argenica Therapeutics (ASX: AGN) \u4e2d\u98ce\u836f\u7269 ARG-007 \u7684\u4e34\u5e8a\u524d\u5b89\u5168\u6027\u7814\u7a76\u5df2\u6210\u529f\u5b8c\u6210\uff0c\u8fd9\u4e3a 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4f26\u7406\u63d0\u4ea4\u94fa\u5e73\u4e86\u9053\u8def\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/argenica-closer-clinical-studies-stroke-drug-arg-007-following-positive-preclinical-safety-results\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-05T00:55:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:53:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Argenica-Therapeutics-ASX-AGN-Good-Manufacturing-Practice-GMP-stroke-therapeutic-ARG-007.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lorna Nicholas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorna Nicholas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/argenica-closer-clinical-studies-stroke-drug-arg-007-following-positive-preclinical-safety-results\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/argenica-closer-clinical-studies-stroke-drug-arg-007-following-positive-preclinical-safety-results\/\",\"name\":\"\u5728\u83b7\u5f97\u79ef\u6781\u7684\u4e34\u5e8a\u524d\u5b89\u5168\u6027\u7ed3\u679c\u540e\uff0cArgenica \u79bb\u4e2d\u98ce\u836f\u7269 ARG-007 \u7684\u4e34\u5e8a\u7814\u7a76\u66f4\u8fd1\u4e86\u4e00\u6b65\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2022-05-05T00:55:47+00:00\",\"dateModified\":\"2023-08-29T17:53:58+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\"},\"description\":\"Argenica Therapeutics (ASX: AGN) \u4e2d\u98ce\u836f\u7269 ARG-007 \u7684\u4e34\u5e8a\u524d\u5b89\u5168\u6027\u7814\u7a76\u5df2\u6210\u529f\u5b8c\u6210\uff0c\u8fd9\u4e3a 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4f26\u7406\u63d0\u4ea4\u94fa\u5e73\u4e86\u9053\u8def\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/argenica-closer-clinical-studies-stroke-drug-arg-007-following-positive-preclinical-safety-results\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/argenica-closer-clinical-studies-stroke-drug-arg-007-following-positive-preclinical-safety-results\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/argenica-closer-clinical-studies-stroke-drug-arg-007-following-positive-preclinical-safety-results\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u5728\u83b7\u5f97\u79ef\u6781\u7684\u4e34\u5e8a\u524d\u5b89\u5168\u6027\u7ed3\u679c\u540e\uff0cArgenica \u79bb\u4e2d\u98ce\u836f\u7269 ARG-007 \u7684\u4e34\u5e8a\u7814\u7a76\u66f4\u8fd1\u4e86\u4e00\u6b65\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\",\"name\":\"Lorna Nicholas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"caption\":\"Lorna Nicholas\"},\"description\":\"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u5728\u83b7\u5f97\u79ef\u6781\u7684\u4e34\u5e8a\u524d\u5b89\u5168\u6027\u7ed3\u679c\u540e\uff0cArgenica \u79bb\u4e2d\u98ce\u836f\u7269 ARG-007 \u7684\u4e34\u5e8a\u7814\u7a76\u66f4\u8fd1\u4e86\u4e00\u6b65","description":"Argenica Therapeutics (ASX: AGN) \u4e2d\u98ce\u836f\u7269 ARG-007 \u7684\u4e34\u5e8a\u524d\u5b89\u5168\u6027\u7814\u7a76\u5df2\u6210\u529f\u5b8c\u6210\uff0c\u8fd9\u4e3a 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4f26\u7406\u63d0\u4ea4\u94fa\u5e73\u4e86\u9053\u8def\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"\u5728\u83b7\u5f97\u79ef\u6781\u7684\u4e34\u5e8a\u524d\u5b89\u5168\u6027\u7ed3\u679c\u540e\uff0cArgenica \u79bb\u4e2d\u98ce\u836f\u7269 ARG-007 \u7684\u4e34\u5e8a\u7814\u7a76\u66f4\u8fd1\u4e86\u4e00\u6b65","og_description":"Argenica Therapeutics (ASX: AGN) \u4e2d\u98ce\u836f\u7269 ARG-007 \u7684\u4e34\u5e8a\u524d\u5b89\u5168\u6027\u7814\u7a76\u5df2\u6210\u529f\u5b8c\u6210\uff0c\u8fd9\u4e3a 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4f26\u7406\u63d0\u4ea4\u94fa\u5e73\u4e86\u9053\u8def\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/argenica-closer-clinical-studies-stroke-drug-arg-007-following-positive-preclinical-safety-results\/","og_site_name":"smallcapsCN","article_published_time":"2022-05-05T00:55:47+00:00","article_modified_time":"2023-08-29T17:53:58+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Argenica-Therapeutics-ASX-AGN-Good-Manufacturing-Practice-GMP-stroke-therapeutic-ARG-007.jpg","type":"image\/jpeg"}],"author":"Lorna Nicholas","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Lorna Nicholas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/argenica-closer-clinical-studies-stroke-drug-arg-007-following-positive-preclinical-safety-results\/","url":"https:\/\/smallcapscn.x5view.co\/argenica-closer-clinical-studies-stroke-drug-arg-007-following-positive-preclinical-safety-results\/","name":"\u5728\u83b7\u5f97\u79ef\u6781\u7684\u4e34\u5e8a\u524d\u5b89\u5168\u6027\u7ed3\u679c\u540e\uff0cArgenica \u79bb\u4e2d\u98ce\u836f\u7269 ARG-007 \u7684\u4e34\u5e8a\u7814\u7a76\u66f4\u8fd1\u4e86\u4e00\u6b65","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2022-05-05T00:55:47+00:00","dateModified":"2023-08-29T17:53:58+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60"},"description":"Argenica Therapeutics (ASX: AGN) \u4e2d\u98ce\u836f\u7269 ARG-007 \u7684\u4e34\u5e8a\u524d\u5b89\u5168\u6027\u7814\u7a76\u5df2\u6210\u529f\u5b8c\u6210\uff0c\u8fd9\u4e3a 1 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u4f26\u7406\u63d0\u4ea4\u94fa\u5e73\u4e86\u9053\u8def\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/argenica-closer-clinical-studies-stroke-drug-arg-007-following-positive-preclinical-safety-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/argenica-closer-clinical-studies-stroke-drug-arg-007-following-positive-preclinical-safety-results\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/argenica-closer-clinical-studies-stroke-drug-arg-007-following-positive-preclinical-safety-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"\u5728\u83b7\u5f97\u79ef\u6781\u7684\u4e34\u5e8a\u524d\u5b89\u5168\u6027\u7ed3\u679c\u540e\uff0cArgenica \u79bb\u4e2d\u98ce\u836f\u7269 ARG-007 \u7684\u4e34\u5e8a\u7814\u7a76\u66f4\u8fd1\u4e86\u4e00\u6b65"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60","name":"Lorna Nicholas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","caption":"Lorna Nicholas"},"description":"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.","url":"https:\/\/smallcapscn.x5view.co\/?author=3"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/5099"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5099"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/5099\/revisions"}],"predecessor-version":[{"id":14978,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/5099\/revisions\/14978"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/13105"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5099"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5099"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5099"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}